Clinical Trial Update: Rifaximin SSD in Dementia Trial [Phase 1, Phase 2]

View source ↗

Summary

The document reports an ongoing Phase 1/2 clinical trial evaluating rifaximin SSD for dementia, currently recruiting in patients with Alzheimer's-type dementia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Vascular Dementia

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Jasmohan Bajaj | Conditions: Dementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease | Phase 1, Phase 2 | Status: RECRUITING